封面
市場調查報告書
商品編碼
2031178

2026-2034年全球心律不整管理設備市場規模、佔有率、趨勢及成長分析報告

Global Arrhythmia Management Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 157 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球心律不整管理設備市場預計將從2025年的91.7億美元成長至2034年的182.6億美元,2026年至2034年的複合年成長率(CAGR)為7.96%。該市場正經歷強勁成長,主要受心律不整盛行率上升和對先進心臟護理解決方案需求不斷成長的推動。心律不整管理設備,例如心律調節器、去心房顫動和監測系統,對於心律不整的診斷和治療至關重要。人口老化和心血管疾病發生率的上升也顯著促進了市場擴張。

推動市場成長的關鍵因素包括醫療技術的進步、醫療保健成本的上升以及人們對心血管健康的日益重視。微創設備和穿戴式監測系統的研發正在改善患者的治療效果並提升就醫便利性。此外,數位健康技術和遠端監測解決方案的整合也增強了疾病管理。政府促進心血管健康的措施也為市場成長提供了支持。

展望未來,設備設計和數位化整合的持續創新預計將對市場產生積極影響。人工智慧診斷工具和智慧型設備的開發將提高治療的準確性和效率。在新興市場,隨著醫療基礎設施的改善,可能會出現巨大的成長機會。隨著人們對心臟護理的關注度不斷提高,心律不整管理設備市場預計將持續擴張。

我們的報告經過精心撰寫,旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分,旨在幫助您全面了解市場環境:

市場概覽:本節提供清晰的市場概覽,包括關鍵定義、分類和當前產業格局。

市場動態:對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析:本部分依據產品類型、應用、最終使用者和地區,將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局:我們對主要市場參與企業的市場定位、產品系列、策略舉措和財務表現進行了詳細評估。這為了解競爭趨勢和主要參與者所採取的策略提供了寶貴的見解。

市場預測:本預測是基於特定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析,揭示未來預期趨勢。

區域分析:本部分全面回顧了主要地理區域的市場表現,確定了高成長領域和區域趨勢,從而更深入地了解區域市場機會。

新趨勢與新機會:識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項:我們提供靈活的客製化服務,可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察,以更好地支持您的策略決策。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章:全球心律不整管理設備市場:依類型分類

  • 市場分析、洞察與預測
  • 心電圖監測儀
  • 植入式監測器
  • 心電圖監測
  • 移動心電遙測

第5章 全球心律不整管理設備市場:依應用分類

  • 市場分析、洞察與預測
  • 心搏過緩
  • 心搏過速
  • 心房顫動
  • 心室顫動
  • 早搏
  • 其他

第6章 全球心律不整管理設備市場:依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院和診所
  • 門診部
  • 診斷中心
  • 其他

第7章 全球心律不整管理設備市場:依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第9章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Abbott Laboratories
    • ACS Diagnostics
    • GE HealthCare
    • BIOTRONIK SE & Co. KG
    • IRhythm Technologies Inc
    • Medtronic Plc
    • Koninklijke Philips NV
    • FUKUDA DENSHI Corporation
    • Spacelabs Healthcare
    • AliveCor Inc
簡介目錄
Product Code: VMR112115172

The global arrhythmia management devices market size is expected to reach USD 18.26 Billion in 2034 from USD 9.17 Billion in 2025, growing at a CAGR of 7.96 during 2026-2034.This market is experiencing strong growth driven by the increasing prevalence of cardiac arrhythmias and the growing demand for advanced cardiac care solutions. Arrhythmia management devices, including pacemakers, defibrillators, and monitoring systems, are essential for diagnosing and treating irregular heart rhythms. The rising aging population and increasing incidence of cardiovascular diseases are significantly contributing to market expansion.

Major drivers include advancements in medical technology, increasing healthcare expenditure, and growing awareness about heart health. The development of minimally invasive devices and wearable monitoring systems is improving patient outcomes and convenience. Additionally, the integration of digital health technologies and remote monitoring solutions is enhancing disease management. Government initiatives promoting cardiovascular health are also supporting market growth.

Looking ahead, the market is expected to benefit from continuous innovation in device design and digital integration. The development of AI-driven diagnostic tools and smart devices will enhance treatment accuracy and efficiency. Emerging markets are likely to offer significant growth opportunities due to improving healthcare infrastructure. As the focus on cardiac care intensifies, the arrhythmia management devices market is set for sustained expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

  • ECG Monitors
  • Implantable Monitors
  • Holter Monitors
  • Mobile Cardiac Telemetry

By Application

  • Bradycardia
  • Tachycardia
  • Atrial Fibrillation
  • Ventricular Fibrillation
  • Premature Contraction
  • Others

By End User

  • Hospitals and Clinics
  • Ambulatory Centers
  • Diagnostic Centers
  • Others

COMPANIES PROFILED

  • Abbott Laboratories, ACS Diagnostics, GE HealthCare, BIOTRONIK SE & Co. KG, iRhythm Technologies Inc., Medtronic plc, Koninklijke Philips N.V., FUKUDA DENSHI Corporation, Spacelabs Healthcare, AliveCor Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL ARRHYTHMIA MANAGEMENT DEVICES MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. ECG Monitors Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Implantable Monitors Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Holter Monitors Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Mobile Cardiac Telemetry Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ARRHYTHMIA MANAGEMENT DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Bradycardia Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Tachycardia Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Atrial Fibrillation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Ventricular Fibrillation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Premature Contraction Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ARRHYTHMIA MANAGEMENT DEVICES MARKET: BY END USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Hospitals and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Ambulatory Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ARRHYTHMIA MANAGEMENT DEVICES MARKET: BY REGION 2022-2034 (USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Type
    • 7.2.2 By Application
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Type
    • 7.3.2 By Application
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Type
    • 7.4.2 By Application
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Type
    • 7.5.2 By Application
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Type
    • 7.6.2 By Application
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ARRHYTHMIA MANAGEMENT DEVICES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Abbott Laboratories
    • 9.2.2 ACS Diagnostics
    • 9.2.3 GE HealthCare
    • 9.2.4 BIOTRONIK SE & Co. KG
    • 9.2.5 IRhythm Technologies Inc
    • 9.2.6 Medtronic Plc
    • 9.2.7 Koninklijke Philips N.V
    • 9.2.8 FUKUDA DENSHI Corporation
    • 9.2.9 Spacelabs Healthcare
    • 9.2.10 AliveCor Inc